Welcome to the European Hematology and Blood Disorders Congress, scheduled for April 14-15, 2025, in the historic city of Rome, Italy. This prestigious congress brings together hematologists, oncologists, researchers, clinicians, and healthcare professionals from around the globe to delve into the latest advancements in hematology and blood disorders.
Attendees can expect a comprehensive program featuring keynote presentations, interactive workshops, poster sessions, and panel discussions covering a wide range of topics. These include hematologic malignancies, benign hematologic disorders, transfusion medicine, stem cell transplantation, immunotherapy, and precision medicine in hematology.
The congress serves as a vital platform for knowledge exchange, networking, and collaboration among experts and stakeholders in the field. Participants will have the opportunity to explore innovative therapies, discuss emerging research findings, and address challenges in hematology practice and patient care.
Join us in Rome to contribute to advancements in hematology and blood disorders, forging connections that drive progress and improve outcomes for patients worldwide.
Abstract Submission Deadline: Sep 26, 2024
Early Bird Registration: Sep 30, 2024
Mid Term Registration: Oct 30, 2024
Final/Onsite Registration: Apr 14, 2025
Director, University of Saskatchewan
Canada
Director, University of Utah
USA
Professor, University of Iowa Health Care
USA
Director, Cardiovascular Research Institute
Israel
Associate Researcher, Biocruces Bizkaia Research Institute
Spain
Peeref is a multidisciplinary platform that supports open science communication and publishing. Peeref has a diamond open access policy and is committed to a publication system that allows free access to published content, whilst also removing publication fees. Peeref allows users to share their work openly, so they can gain feedback from the international research community. Through sharing and other tools available on Peeref, you can learn about breakthroughs in your field and identify potential collaborators.